42492-62-6

Usage

Chemical Properties

White powder

InChI:InChI=1/C13H19NO2/c1-10(2)12(13(15)16)14(3)9-11-7-5-4-6-8-11/h4-8,10,12H,9H2,1-3H3,(H,15,16)

Upstream product

• 50-00-0 formaldehyd 
• 15363-84-5 (S)-2-(benzylamino)-3-methylbutanoic acid 
• 100-52-7 benzaldehyde 
• 72-18-4 L-valine 
• 74-88-4 methyl iodide 
• 2480-23-1 N-methylvaline 
• 100-44-7 benzyl chloride 

Downstream Products

• 1007880-07-0 2-(benzyl(methyl)amino)-3-methylbutanoic acid trifluoroacetic acid salt 
• 101617-29-2 (S)-2-(Benzyl-methyl-amino)-3-methyl-butyric acid (S)-1-tert-butoxycarbonyl-2-methyl-propyl ester 
• 101617-28-1 (S)-2-(Benzyl-methyl-amino)-3-methyl-butyric acid (R)-1-tert-butoxycarbonyl-2-methyl-propyl ester 
• 35016-37-6 N-methyl-L-valine methyl ester 
• 118460-23-4 (S)-methyl 2-(benzyl(methyl)amino)-3-methylbutanoate 

Relevant academic research and scientific papers

Hepatitis C Virus Inhibitors

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Synthesis and utilization of a novel glycine derived chiral precursor, based on a recyclable L-prolinol auxiliary, for the enantioselective preparation of α-amino acids and their N-methyl derivatives

α-Amino acids and their N-methyl derivatives are synthesized in fairly high optical purity employing a new glycine derived template based on a recyclable L-prolinol chiral auxiliary.